Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.vistapharmaceuticals.com | |
Market Cap | 75.07 Cr. | |
Enterprise Value(EV) | 84.33 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -1.71 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.75 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 8.74 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 1.89 | Calculated using Price: 16.49 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 4.55 Cr. | 45,524,899 Shares |
FaceValue | 2 | |
About Vista Pharmaceuticals Ltd. | ||
Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America. |
1 Day |
|
+1.98% |
1 Week |
|
-3.96% |
1 Month |
|
+14.91% |
3 Month |
|
+21.07% |
6 Month |
|
+100.85% |
1 Year |
|
+117.55% |
2 Year |
|
+68.44% |
5 Year |
|
-25.05% |
10 Year |
|
+438.89% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 13.94 | 7.15 | 8.97 | 10.19 | 3.15 | -11.68 | -6.43 | -2.60 | -17.16 | |
Return on Capital Employed (%) | 14.16 | 9.57 | 8.92 | 12.42 | 6.28 | -5.20 | -5.10 | -3.75 | -9.85 | |
Return on Assets (%) | 7.39 | 3.15 | 3.70 | 4.67 | 1.78 | -7.11 | -3.89 | -1.70 | -10.73 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 10 | 11 | 17 | 32 | 36 | 30 | 33 | 35 | 37 | 39 | |
Non Curr. Liab. | 0 | 8 | 5 | 6 | 6 | 5 | 11 | 4 | 3 | 2 | |
Curr. Liab. | 12 | 7 | 19 | 15 | 11 | 16 | 9 | 13 | 14 | 14 | |
Minority Int. | |||||||||||
Equity & Liab. | 23 | 26 | 41 | 53 | 53 | 51 | 53 | 52 | 53 | 54 | |
Non Curr. Assets | 11 | 10 | 16 | 25 | 29 | 30 | 37 | 29 | 30 | 30 | |
Curr. Assets | 12 | 16 | 26 | 28 | 23 | 21 | 15 | 24 | 24 | 24 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 23 | 26 | 41 | 53 | 53 | 51 | 53 | 52 | 53 | 54 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 14 | 15 | 24 | 29 | 31 | 23 | 1 | 0 | 1 | 6 | |
Other Income | 0 | 0 | 0 | 0 | 3 | 4 | 0 | 0 | 0 | 1 | |
Total Income | 14 | 15 | 24 | 29 | 34 | 27 | 1 | 1 | 1 | 7 | |
Total Expenditure | -11 | -13 | -21 | -24 | -30 | -28 | -3 | -2 | -5 | -10 | |
PBIDT | 3 | 3 | 3 | 6 | 4 | -1 | -2 | -1 | -4 | -3 | |
Interest | 0 | -1 | -1 | -2 | -2 | -2 | -2 | -1 | -1 | -1 | |
Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | |
Taxation | 0 | 0 | 0 | -1 | 0 | 0 | 2 | 2 | 0 | -2 | |
Exceptional Items | |||||||||||
PAT | 1 | 1 | 1 | 2 | 1 | -4 | -2 | -1 | -6 | -8 | |
Adjusted EPS | 1 | 0 | 0 | 1 | 0 | -1 | -1 | 0 | -2 | -2 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | -4 | -3 | 3 | -5 | 3 | 1 | -7 | -1 | -2 | |
Cash Fr. Inv. | 0 | 0 | 0 | -4 | -11 | -6 | -2 | 0 | 0 | -1 | |
Cash Fr. Finan. | 4 | 3 | 6 | 11 | 1 | 0 | 7 | 1 | 3 | ||
Net Change | 0 | 0 | 5 | -4 | -1 | -1 | 0 | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 6 | 2 | 1 | 0 | 0 | 0 | 0 |
Tue, 28 Nov 2023
Announcement under Regulation 30 (LODR)-Allotment Kindly take note of the allotment of 6 40 000 equity shares pursuant to the conversion of 6 40 000 warrants issued to others on a private placement basis |
Fri, 10 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 10.11.2023 It is hereby informed that the Meeting of the Board of Directors of the Company was held on Friday 10th November 2023.at 04:00 PM and ended at 05:55 PM at the corporate office of the Company. |
Fri, 10 Nov 2023
Results Financial Results As Of 30.09.2023. Copy of unaudited Financial Results for the quarter and half year ended 30.09.2023 along with Limited Review Report is enclosed herewith |
Fri, 01 Dec 2023 |
|
|
|
|
|